Arcturus Therapeutics Holdings Inc. business relationships
Companies named in Arcturus Therapeutics Holdings Inc.’s 10-K filed 2026-03-03, and public companies whose annual reports name Arcturus Therapeutics Holdings Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 6.1 / 10
- AI naming
- 100 / 100 Top 1% in its category
- Agent readiness
- 40 / 100
- AI adoption
- 0 / 100
Named in Arcturus Therapeutics Holdings Inc.’s annual report 9
“We have built a global manufacturing footprint with our partners, including Aldevron, Catalent, Recipharm, Polymun and ARCALIS.” SEC filing
“Collaboration and License Agreement, dated November 1, 2022, by and between Arcturus Therapeutics Holdings Inc. and CSL Limited.” SEC filing
“...2022, we entered into a Collaboration and License Agreement ("CSL Collaboration Agreement") with CSL Seqirus, a part of CSL Limited and one of the world's leading influenza vaccine providers, for the global exclusive rights to research, develop, manufacture and commercialize self-amplifying mRNA vac...” SEC filing
“Through the Moderna-Vertex collaboration, the mRNA-3692 / VX-522 asset for CF is in Phase I.” SEC filing
“We have built a global manufacturing footprint with our partners, including Aldevron, Catalent, Recipharm, Polymun and ARCALIS.” SEC filing
“The mRNA portfolio resulting from the GSK-CureVac collaboration focuses on vaccines in the prevention of influenza and COVID-19 viruses.” SEC filing
“We have built a global manufacturing footprint with our partners, including Aldevron, Catalent, Recipharm, Polymun and ARCALIS.” SEC filing
“We have built a global manufacturing footprint with our partners, including Aldevron, Catalent, Recipharm, Polymun and ARCALIS.” SEC filing
“Equity method investment activity is related to the Company's joint venture in ARCALIS, Inc. with Axcelead, Inc. The Company's share of the investees' results is presented as either income or loss from equity method investees in the accompanying consolidated statements of operations and comprehensiv...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.